An international team of investigators based in the United States and Germany has modified the nanoscale printing technique known as dip-pen nanolithography to create large numbers of model cell membranes. This method, published in the journal Small, could open the door to a better understanding of how the cell membrane functions and could lead to new ways of getting therapeutic drugs into cells.
Cell membranes are incredibly complex structures comprising a mixture of fatty molecules known collectively as phospholipids, proteins, and numerous other molecules, including cholesterol. These components hold each other together in a fluid manner –while the overall structure of the cell membrane is durable, the individual molecules in it are relatively free to move around within the confines of the membrane.
Chad Mirkin, Ph.D., and colleagues at Northwestern University, and Steven Lenhert, Ph.D., and his collaborators at the University of Munster in Germany, worked together on this project. Mirkin, who is the principal investigator of the Nanomaterials for Cancer Diagnostics and Therapeutics Center for Cancer Nanotechnology Excellence, invented dip-pen nanolithography, which uses an atomic force microscope to place individual molecules onto a surface, such as a glass slide or silicon chip.
In this work, the investigators determined the optimal experimental conditions needed to use phospholipids as “ink” that they could print onto glass slides, polystyrene sheets, or silicon wafers. By carefully controlling the humidity and application rate, the researchers were able to deposit multiple phospholipids in precise patterns. Once deposited onto a substrate, the phospholipids formed a lipid bi-layer characteristic of cell membranes. The investigators note that they should be able to use dip-pen nanolithography to design the type of complex physical and chemical networks of materials that are found in cell membranes.
This work is detailed in a paper titled, “Massively parallel dip-pen nanolithography of heterogeneous supported phospholipid multilayer patterns.” Investigators from Forschungszentrum Karlsruhe in Germany also participated in this study. An abstract of this paper is available at the
journal’s website.
Source: National Cancer Institute
Related stories:
Do 68 molecules hold the key to understanding disease?
Why is it that the origins of many serious diseases remain a mystery? In considering that question, a scientist at the University of California, San Diego School of Medicine has come up with a unified molecular view of the indivisible unit of life, the cell, which may provide an answer.
Unsuccessful drug against anxiety opens a novel gateway for the treatment of cancer
Unsatisfying drug for anxiety reveals scientists a promising novel anti-cancer drug target. Cancer cells have multiple ways to avoid apoptosis, programmed cell death the means by which organisms deal with defective cells. One defense is to produce quantities of phosphatic acid, a phospholipid constituent of cellular membranes.
Fatal protein interactions may explain neurological diseases
In a collaborative study at the University of California, San Diego, investigators from neurosciences, chemistry and medicine, as well as the San Diego Supercomputer Center (SDSC) have investigated how proteins involved in neurodegenerative diseases such as Alzheimer's and Parkinson's disease interact to form unique complexes. Their findings explain why Alzheimer's patients might develop Parkinson's, and vice versa. The new and unique molecular structures they discovered can now be used to model and develop new drugs for these devastating neurological diseases. Their findings will be published in the September 3 issue of
Public Library of Science (PLoS) ONE on September 4, 2008.
A sharper look at malaria
(PhysOrg.com) -- In work that could lead to new ways of detecting and treating malaria, MIT researchers have used two advanced microscopy techniques to show in unprecedented detail how the malaria parasite attacks red blood cells.
Brain physiology of prenatal alcohol exposure uncovered
(PhysOrg.com) -- University of Alberta researchers have identified several regions of the brain that appear to be altered in children with Fetal Alcohol Spectrum Disorder.
ABC-transporters expressed on endothelial cell membranes efflux anti-HIV drugs
Researchers at Tulane University Medical Center in New Orleans (USA) have discovered that drug-efflux pumps, belonging to the ATP-binding cassette (ABC) transporter family, are constitutively expressed on vascular endothelial cells. Transcripts for several different ABC-transporters, e.g. MDR-1 (P-gp) and MRPs, were detected in endothelial cells, obtained from brain, aortic artery, pulmonary artery, dermal microvessels and umbilical veins.
Century-old rule of chemistry overturned -- major implications for drug delivery
A new study by research chemists at the University of Warwick has challenged a century old rule of pharmacology that defined how quickly key chemicals can pass across cell walls. The new observations of the Warwick researchers suggest that the real transport rates could be up to a hundred times slower than predicted by the century old "Overton's Rule". This could have major implications for the development and testing of many future drugs.
Infection blocks lung's protective response against tobacco smoke
An infection that often goes undetected can block the lung's natural protective response against tobacco smoke, according to researchers at National Jewish Health. The findings, recently published online and scheduled to appear in the October issue of
Infection and Immunity, suggest one mechanism that may cause smokers to develop chronic obstructive pulmonary disease.